Myasthenia gravis
Upcoming SlideShare
Loading in...5
×
 

Myasthenia gravis

on

  • 1,055 views

 

Statistics

Views

Total Views
1,055
Views on SlideShare
1,055
Embed Views
0

Actions

Likes
0
Downloads
26
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Myasthenia gravis Myasthenia gravis Presentation Transcript

  • Presented by: Jessica Faye Manansala
  •  Myasthenia gravis, an autoimmune disorder affecting the myoneural junction, is characterized by varying degrees of weakness of the voluntary muscles. Women tend to develop the disease at an early age (20-40 yrs of age) In men (60-70 yrs of age)
  •  Ocular muscle – diplopia (double vision) Ptosis (drooping of the eyelid)Major signs and symptoms Bulbar symptom- weakness of the muscle of face and throat Generalized weakness- resulting decrease vital capacity and respiratory failure Dysphonia (voice impairment)- this may result increase risk for choking and aspirationMyasthenia gravis is purely a motor disorder with noeffect on sensation or coordination.
  •  Myasthenic crisis Cholinergic crisis
  •  is an exacerbation of the diseaes process. Crisis may result from disease exacerbation or a specific precipitation event.Most common precipitator is infection; medicattion change, surgery, pregnancy and high environmental temp.Symptoms Severe generalized muscle weakness and respiratory And bulbar weakness that may result respiratory failure
  •  Symptoms of anticholinergic overmedication may mimic the symptoms of exacerbation Differentation can be achieved with the edrophonium chloride (tensilon) test.Difference between myasthenic & cholinergicMyasthenic- improves immediately following adminstration of edrophoniumCholinergic- crisis may experience no improvement or deteriorate
  • Myasthenic crisis – neostigmine methylsulfate, prostigmine is admin IM or IV until the pt. is able to swallow oral anticholinestrase meds.-plasma pheresis and IVIG- reduce antibody loadCholinergic crisis – all anticholinestrase meds should be stop- Atrophine sulfate should be given- an antidote for anticholinestrase medication.
  •  Anti cholinestrase test Edrophonium chloride (tensilon) injected through IV- 2mg at a time to a total of 10mg (30sec after injection, facial muscle weakness & ptosis should resolve for about 5min=+). Atrophine (o.4mg)should availabale for side effects. Repetitive nerve stimulation test- it records the electrical activity in target muscle after nerve stimulation. MRI- for enlarged thymus gland
  • Administration of anticholinestrase agent Pyridostigmine bromide (mestinon) & neostigmine bromide (prostigmine)Effect: provide symptomatic refief by increasing the relative concentration of available acetylcholine at the neuro muscular junction. Improve strength and less fatigueImmunosuppresive therapy CorticosteroidsEffect: to reduce production of the antibodyPrednisone taken on alternate days to lower the incidence of side effects.
  •  Plasmapheresis- blood cells & antibody containing plasma are separated, then cells and plasma substitutes are reinfused.Effect: plasma exchange used to treat exacerbations. The improvement may last only a few weeksIV immune globulin – nearly effective as plasmapheresis in controlling symptoms exacerbation. Thymectomy - it can decrease or eliminate the need for medication